CVS Health (CVS) shares powered 7% higher Thursday after the pharmacy and healthcare giant's first-quarter results handily topped estimates.

Revenue grew 7% year-over-year to $94.59 billion, while adjusted 澳洲幸运5官方开奖结果体彩网:earnings per share (EPS) rose more than 70% to $2.25. Each ꦛmetric came in well above the analyst consensus compiled by Visible A💫lpha.

The company trimmed its EPS guidance range to $4.23 to $4.43, down from $꧋4.58 to $4.83 previously. However, CVS lifted its adjusted EPS projection to $6.00 to $6.20, up from its previous range of $5.75 to $6.00.

The pharmacy chain and Aetna health insurance operator said it updated its outlook to "reflect strong performance across each of our businesses, while maintaining a cautious view for the remainder of the year in light of continued elevated cost trends and the potential for macro headwinds."

Last month, 澳洲幸运5官方开奖结果体彩网:the company said it would like💜ly meet or exceed that adjusted EPS range, and appointed a new CFO, Brian Newman.

CVS Health 🃏shares are up nearly 60% since the start of the year and are trading at their highest level since April 2024.

UPDATE—This article has been updated with the latest share price information.